CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Nitroglycerin for the Treatment of Pulmonary Edema Following Submersion: Clinical Effectiveness and Guidelines

Last updated: March 11, 2014
Project Number: RB0662-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of nitroglycerin for the treatment of pulmonary edema secondary to submersion, in pre- or in-hospital settings?
  2. What are the evidence-based guidelines regarding the use of nitroglycerin for the treatment of pulmonary edema secondary to submersion, in pre- or in-hospital settings?

Key Message

No relevant health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, or evidence-based guidelines were identified regarding the use of nitroglycerin for the treatment of pulmonary edema secondary to submersion in pre- or in-hospital settings.